Oracle launches unified health data exchange console
LONDON - Frontier IP Group Plc (AIM:FIPP) announced Thursday that Chief Commercialisation Officer Matthew White will leave the company to become CEO of an early-stage medical devices company based in Cambridge.
White, who has served as Chief Commercialisation Officer for seven years, will remain with Frontier IP until the end of his six-month notice period on March 24, 2026, according to the company’s statement.
The intellectual property commercialisation specialist said it is currently in discussions about a successor and will provide further updates when appropriate.
Neil Crabb, Frontier IP’s Chief Executive Officer, described the departure as "wholly amicable" and acknowledged White’s "invaluable role in the progress made by Frontier IP and our portfolio companies."
White stated that it had been "a privilege to be involved in the development of the Frontier IP portfolio" during his tenure and expressed optimism about "Frontier IP’s growing engagement in the Cambridge deeptech ecosystem."
The announcement was made in a regulatory news service filing to the London Stock Exchange.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.